| Nome |
# |
|
alpha-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication, file dd8a4bf7-e251-20a0-e053-d805fe0a8cb0
|
259
|
|
Astrocytes-derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein, file dd8a4bf9-0c1d-20a0-e053-d805fe0a8cb0
|
173
|
|
In Vitro Aggregation Assays for the Characterization of α-synuclein Prion-Like Properties, file dd8a4bf7-1def-20a0-e053-d805fe0a8cb0
|
132
|
|
Mycobacterium tuberculosis chaperonin 10 forms stable tetrameric and heptameric structures. Implications for its diverse biological activities, file dd8a4bf7-1e8c-20a0-e053-d805fe0a8cb0
|
127
|
|
alpha-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication, file dd8a4bf7-e250-20a0-e053-d805fe0a8cb0
|
119
|
|
Structural Consequences of Copper Binding to the Prion Protein, file dd8a4bf8-d559-20a0-e053-d805fe0a8cb0
|
107
|
|
Characterization of prion protein function by focal neurite stimulation, file dd8a4bf7-267e-20a0-e053-d805fe0a8cb0
|
101
|
|
NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features, file dd8a4bf7-0ff5-20a0-e053-d805fe0a8cb0
|
84
|
|
On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases, file dd8a4bf8-e0d1-20a0-e053-d805fe0a8cb0
|
80
|
|
The Priority position paper: Protecting Europe's food chain from prions, file dd8a4bf7-2237-20a0-e053-d805fe0a8cb0
|
77
|
|
Whole blood gene expression profiling in preclinical and clinical cattle infected with atypical bovine spongiform encephalopathy, file dd8a4bf7-267f-20a0-e053-d805fe0a8cb0
|
62
|
|
Molecular pathogenesis of prion diseases, file dd8a4bf7-80d3-20a0-e053-d805fe0a8cb0
|
61
|
|
The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein, file dd8a4bf7-e893-20a0-e053-d805fe0a8cb0
|
59
|
|
The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion, file dd8a4bf8-3a14-20a0-e053-d805fe0a8cb0
|
58
|
|
The N Terminus of the Prion Protein Mediates Functional Interactions with the Neuronal Cell Adhesion Molecule (NCAM) Fibronectin Domain, file dd8a4bf8-33b7-20a0-e053-d805fe0a8cb0
|
57
|
|
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations, file dd8a4bf7-e71f-20a0-e053-d805fe0a8cb0
|
54
|
|
Small-Molecule Theranostic Probes: A Promising Future in Neurodegenerative Diseases, file dd8a4bf7-1d90-20a0-e053-d805fe0a8cb0
|
53
|
|
Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy, file dd8a4bf8-e066-20a0-e053-d805fe0a8cb0
|
53
|
|
Probing Early Misfolding Events in Prion Protein Mutants by NMR Spectroscopy, file dd8a4bf7-1d8f-20a0-e053-d805fe0a8cb0
|
45
|
|
Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases, file dd8a4bf7-e7f6-20a0-e053-d805fe0a8cb0
|
45
|
|
Defined α-synuclein prion-like molecular assemblies spreading in cell culture, file dd8a4bf7-1e0e-20a0-e053-d805fe0a8cb0
|
44
|
|
Elucidating the function of the prion protein, file dd8a4bf7-eb0c-20a0-e053-d805fe0a8cb0
|
44
|
|
Synthetic prions with novel strain-specified properties, file dd8a4bf7-1455-20a0-e053-d805fe0a8cb0
|
43
|
|
Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure, file dd8a4bf8-a506-20a0-e053-d805fe0a8cb0
|
43
|
|
The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion, file dd8a4bf7-1773-20a0-e053-d805fe0a8cb0
|
40
|
|
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques, file dd8a4bf7-176d-20a0-e053-d805fe0a8cb0
|
36
|
|
Pin1 and neurodegeneration: a new player for prion disorders?, file dd8a4bf8-3085-20a0-e053-d805fe0a8cb0
|
35
|
|
Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation, file dd8a4bf7-1be8-20a0-e053-d805fe0a8cb0
|
34
|
|
Soil humic substances hinder the propagation of prions, file dd8a4bf8-2dcc-20a0-e053-d805fe0a8cb0
|
34
|
|
In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution, file dd8a4bf7-1451-20a0-e053-d805fe0a8cb0
|
33
|
|
Effect of extracellular vesicles derived from distinct brain cells on A beta toxicity and assembly: focus on microglia derived vesicles, file dd8a4bf7-e07f-20a0-e053-d805fe0a8cb0
|
33
|
|
A novel expression system for production of soluble prion proteins in E.coli, file dd8a4bf8-3146-20a0-e053-d805fe0a8cb0
|
33
|
|
Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids, file dd8a4bf8-db11-20a0-e053-d805fe0a8cb0
|
33
|
|
The alpha-synuclein RT-QuIC products generated by the olfactory mucosa of patients with parkinson’s disease and multiple system atrophy induce inflammatory responses in SH-SY5Y cells, file dd8a4bf9-0c1e-20a0-e053-d805fe0a8cb0
|
33
|
|
Modulation of alpha-synuclein aggregation by dopamine analogs, file dd8a4bf7-1cfd-20a0-e053-d805fe0a8cb0
|
31
|
|
Prion protein interaction with soil humic substances: environmental implications, file dd8a4bf7-26ec-20a0-e053-d805fe0a8cb0
|
31
|
|
Prion and prion-like protein strains: Deciphering the molecular basis of heterogeneity in neurodegeneration, file dd8a4bf8-d47a-20a0-e053-d805fe0a8cb0
|
31
|
|
New insights into structural determinants of prion protein folding and stability, file dd8a4bf7-20a2-20a0-e053-d805fe0a8cb0
|
29
|
|
Prion protein-specific antibodies-development, modes of action and therapeutics application, file dd8a4bf7-176f-20a0-e053-d805fe0a8cb0
|
28
|
|
Unique Structural Features of Mule Deer Prion Protein Provide Insights into Chronic Wasting Disease, file dd8a4bf8-d7e8-20a0-e053-d805fe0a8cb0
|
27
|
|
Prion protein paralog doppel protein interacts with alpha-2-macroglobulin: a plausible mechanism for doppel-mediated neurodegeneration, file dd8a4bf7-1d1f-20a0-e053-d805fe0a8cb0
|
26
|
|
Differential overexpression of SERPINA3 in human prion diseases, file dd8a4bf7-e9bc-20a0-e053-d805fe0a8cb0
|
26
|
|
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia, file dd8a4bf7-e9f0-20a0-e053-d805fe0a8cb0
|
26
|
|
Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases, file dd8a4bf8-19e2-20a0-e053-d805fe0a8cb0
|
26
|
|
Pmca-generated prions from the olfactory mucosa of patients with fatal familial insomnia cause prion disease in mice, file dd8a4bf9-0a27-20a0-e053-d805fe0a8cb0
|
26
|
|
Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells, file dd8a4bf7-294b-20a0-e053-d805fe0a8cb0
|
25
|
|
Prion protein and aging, file dd8a4bf7-19fe-20a0-e053-d805fe0a8cb0
|
24
|
|
Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c), file dd8a4bf7-1dea-20a0-e053-d805fe0a8cb0
|
24
|
|
PrPC Controls via Protein Kinase A the Direction of Synaptic Plasticity in the Immature Hippocampus, file dd8a4bf7-77b4-20a0-e053-d805fe0a8cb0
|
24
|
|
Early structural features in mammalian prion conformation conversion, file dd8a4bf7-108e-20a0-e053-d805fe0a8cb0
|
23
|
|
De novo prions, file dd8a4bf7-16a8-20a0-e053-d805fe0a8cb0
|
23
|
|
Investigating the conformational stability of prion strains through a kinetic replication model, file dd8a4bf7-1d22-20a0-e053-d805fe0a8cb0
|
23
|
|
Differential overexpression of SERPINA3 in human prion diseases, file dd8a4bf7-e905-20a0-e053-d805fe0a8cb0
|
23
|
|
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies, file dd8a4bf8-dfbc-20a0-e053-d805fe0a8cb0
|
23
|
|
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia, file dd8a4bf7-e2cc-20a0-e053-d805fe0a8cb0
|
21
|
|
Involvement of PrPC in kainate-induced excitotoxicity in several mouse strains, file dd8a4bf8-3c36-20a0-e053-d805fe0a8cb0
|
21
|
|
Cytosolic prion protein in neurons, file dd8a4bf7-1c85-20a0-e053-d805fe0a8cb0
|
20
|
|
Profiling dopamine-induced oxidized proteoforms of β-synuclein by top-down mass spectrometry, file dd8a4bf9-0a12-20a0-e053-d805fe0a8cb0
|
20
|
|
Protease-sensitive synthetic prions, file dd8a4bf7-1128-20a0-e053-d805fe0a8cb0
|
19
|
|
Prion Protein Accumulation In Lipid Rafts of Mouse Aging Brain, file dd8a4bf7-1ded-20a0-e053-d805fe0a8cb0
|
19
|
|
Involvement of PrPC in kainate-induced excitotoxicity in several mouse strains, file dd8a4bf7-26ed-20a0-e053-d805fe0a8cb0
|
19
|
|
Progress towards structural understanding of infectious sheep PrP-amyloid, file dd8a4bf7-1bea-20a0-e053-d805fe0a8cb0
|
18
|
|
The cellular prion protein increases the uptake and toxicity of tdp-43 fibrils, file dd8a4bf9-0cee-20a0-e053-d805fe0a8cb0
|
18
|
|
Pharmacokinetics of quinacrine in the treatment of prion disease, file dd8a4bf8-249f-20a0-e053-d805fe0a8cb0
|
16
|
|
Mapping the prion protein distribution in marsupials: insights from comparing opossum with mouse CNS, file dd8a4bf8-35bb-20a0-e053-d805fe0a8cb0
|
16
|
|
Continuous quinacrine treatment results in the formation of drug-resistant prions, file dd8a4bf7-1595-20a0-e053-d805fe0a8cb0
|
15
|
|
Depicting conformational ensembles of α-synuclein by single molecule force spectroscopy and native mass spectroscopy, file dd8a4bf8-d7e7-20a0-e053-d805fe0a8cb0
|
14
|
|
Chronic α-synuclein accumulation in rat hippocampus induces lewy bodies formation and specific cognitive impairments, file dd8a4bf9-03ca-20a0-e053-d805fe0a8cb0
|
11
|
|
De novo mammalian prion synthesis, file dd8a4bf7-0f7c-20a0-e053-d805fe0a8cb0
|
3
|
|
Structural rearrangements at physiological pH: Nuclear magnetic resonance insights from the V210I human prion protein mutant, file dd8a4bf7-1559-20a0-e053-d805fe0a8cb0
|
3
|
|
Expression and activity of pre-dianthin 30 and dianthin 30, file dd8a4bf7-26fe-20a0-e053-d805fe0a8cb0
|
3
|
|
Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site, file dd8a4bf7-ac60-20a0-e053-d805fe0a8cb0
|
3
|
|
Hybrid lipoic acid derivatives to attack prion disease on multiple fronts, file dd8a4bf7-108b-20a0-e053-d805fe0a8cb0
|
2
|
|
Structural insights into alternate aggregated prion protein forms, file dd8a4bf7-10c1-20a0-e053-d805fe0a8cb0
|
2
|
|
A new approach to follow a single extracellular vesicle-cell interaction using optical tweezers, file dd8a4bf7-1453-20a0-e053-d805fe0a8cb0
|
2
|
|
Cooperative binding of dominant-negative prion protein to kringle domains, file dd8a4bf7-158b-20a0-e053-d805fe0a8cb0
|
2
|
|
Copper coordination in the full-length, recombinant prion protein, file dd8a4bf7-1617-20a0-e053-d805fe0a8cb0
|
2
|
|
Structural determinants in prion protein folding and stability, file dd8a4bf7-1771-20a0-e053-d805fe0a8cb0
|
2
|
|
Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands, file dd8a4bf7-1903-20a0-e053-d805fe0a8cb0
|
2
|
|
Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits, file dd8a4bf7-190d-20a0-e053-d805fe0a8cb0
|
2
|
|
Rational approach to an antiprion compound with a multiple mechanism of action, file dd8a4bf7-19fa-20a0-e053-d805fe0a8cb0
|
2
|
|
Synthetic prions and other human neurodegenerative proteinopathies, file dd8a4bf7-1a00-20a0-e053-d805fe0a8cb0
|
2
|
|
Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites, file dd8a4bf7-1a9d-20a0-e053-d805fe0a8cb0
|
2
|
|
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice, file dd8a4bf7-1c84-20a0-e053-d805fe0a8cb0
|
2
|
|
Discovery of a class of diketopiperazines as antiprion compounds, file dd8a4bf7-1d02-20a0-e053-d805fe0a8cb0
|
2
|
|
Evidence for GroES acting as a transcriptional regulator, file dd8a4bf7-1e8b-20a0-e053-d805fe0a8cb0
|
2
|
|
Differential inhibition of prion propagation by enantiomers of quinacrine, file dd8a4bf7-1f97-20a0-e053-d805fe0a8cb0
|
2
|
|
Cochaperonins are histone-binding proteins, file dd8a4bf7-1fa8-20a0-e053-d805fe0a8cb0
|
2
|
|
Purificazione di proteine di mammifero in biotecnologia, file dd8a4bf7-1fac-20a0-e053-d805fe0a8cb0
|
2
|
|
Humic substances interfere with detection of pathogenic prion protein, file dd8a4bf7-209d-20a0-e053-d805fe0a8cb0
|
2
|
|
Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to α-Synuclein, file dd8a4bf7-213f-20a0-e053-d805fe0a8cb0
|
2
|
|
Human prions and plasma lipoproteins, file dd8a4bf7-218e-20a0-e053-d805fe0a8cb0
|
2
|
|
Synthetic mammalian prions, file dd8a4bf7-21a3-20a0-e053-d805fe0a8cb0
|
2
|
|
Structural Studies of Prion Proteins and Prions, file dd8a4bf7-236c-20a0-e053-d805fe0a8cb0
|
2
|
|
Role of prion disease-linked mutations in the intrinsically disordered N-terminal domain of the prion protein, file dd8a4bf7-2685-20a0-e053-d805fe0a8cb0
|
2
|
|
The peculiar nature of unfolding of the human prion protein, file dd8a4bf7-0f8a-20a0-e053-d805fe0a8cb0
|
1
|
|
Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes, file dd8a4bf7-10b3-20a0-e053-d805fe0a8cb0
|
1
|
|
Gene expression profiling to identify druggable targets in prion diseases, file dd8a4bf7-11a2-20a0-e053-d805fe0a8cb0
|
1
|
|
Oxidation of methionine residues in the prion protein by hydrogen peroxide, file dd8a4bf7-11f2-20a0-e053-d805fe0a8cb0
|
1
|
|
Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc?, file dd8a4bf7-12d6-20a0-e053-d805fe0a8cb0
|
1
|
| Totale |
3.153 |